Genenta strengthens agreement with AGC Biologics to boost cell therapy manufacturing
Source: SeekingAlpha
2025-01-09 06:06:29 ET
More on Genenta Science
- Seeking Alpha’s Quant Rating on Genenta Science
- Historical earnings data for Genenta Science
- Financial information for Genenta Science
Read the full article on Seeking Alpha
For further details see:
Genenta strengthens agreement with AGC Biologics to boost cell therapy manufacturing
Genenta Science S.p.A.
NASDAQ: GNTA
GNTA Trading
13.11% G/L:
$2.07 Last:
5,067,771 Volume:
$1.59 Open:
GNTA Latest News
March 27, 2026 05:00:00 am
Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs
GNTA Stock Data
$21,557,608
14,024,162
N/A
5
N/A
Biotechnology & Life Sciences
Healthcare
IT
Milan
